Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design
ConclusionThis is the largest randomized trial to test if influenza vaccine compared to control reduces adverse vascular events in high risk individuals.Trial registration number:Clinicaltrials.govNCT02762851
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: African Health | Cardiology | Cardiovascular | Heart | Heart Attack | Heart Failure | Influenza | Influenza Vaccine | Middle East Health | Stroke | Vaccines